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Key points summary 
 Tenascin X (TNX) functions in the extracellular matrix of skin and joints to maintain correct 
intercellular connections and tissue architecture 
 TNX is associated exclusively with vagal-afferent endings and some myenteric neurones in 
mouse and human stomach respectively.  
 TNX-deficient mice have accelerated gastric emptying and hypersensitivity of gastric vagal 
mechanoreceptors that can be normalised by an inhibitor of vagal-afferent sensitivity. 
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 Cultured nodose ganglion neurones showed no changes in response to capsaicin, 
cholecystokinin and potassium chloride in TNX-deficient mice. 
 TNX-deficient patients have upper gastric dysfunction consistent with those in mouse-model. 
Our translational studies suggest abnormal gastric sensory function may explain upper gut 
symptoms present in TNX deficient patients, thus making it important to study gastric 
physiology.  
 TNX deficiency should be evaluated routinely in patients with connective tissue abnormalities 
which will enable better understanding of its role and allow targeted treatment. For example, 
inhibitors of vagal afferents-Baclofen could be beneficial in patients. These hypotheses need 
confirmation through targeted clinical-trials.  
ABSTRACT 
Tenascin X (TNX) is a glycoprotein that regulates tissue structure through anti-adhesive interactions 
with collagen in the extracellular matrix. TNX deficiency causes a phenotype similar to hypermobility 
Ehlers Danlos Syndrome (hEDS) involving joint hypermobility, skin hyperelasticity, pain and 
gastrointestinal (GI) dysfunction. Previously, we have shown TNX is required for neural control of the 
bowel by a specific subtype of mainly cholinergic enteric neurones and regulates sprouting and 
sensitivity of nociceptive sensory endings in mouse colon. These findings correlate with symptoms 
shown by TNX-deficient patients and mice. We set out to identify if TNX is similarly present in neural 
structures found in mouse and human gastric tissue. We then determined whether TNX has a 
functional role, specifically in gastric motor and sensory function and nodose ganglia neurones. We 
report TNX was present in calretinin-immunoreactive extrinsic nerve endings in mouse and human 
stomach. TNX deficient mice had accelerated gastric emptying and markedly increased vagal afferent 
responses to gastric distension that could be rescued with GABAB receptor agonist. There were no 
changes in nodose ganglia excitability in TNX deficient mice suggesting vagal afferent responses are 
likely due to altered peripheral mechanosensitivity. In TNXB-deficient patients significantly greater 
symptoms of reflux, indigestion, and abdominal pain was reported.  Here we report the first role for 
TNX in gastric function and further studies are required in TNX deficient patients to determine if 
symptoms can be relieved using GABAB agonists.  
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INTRODUCTION 
TNX is an extracellular matrix glycoprotein belonging to a family of tenascins and other molecules that 
govern tissue structure (Valcourt et al., 2015). Its absence leads to  heritable connective tissue 
disorders with a phenotype similar to hypermobility Ehlers Danlos Syndrome (hEDS) (Zweers et al., 
2004) although TNX deficient patients are now classified as a separate subgroup (Malfait et al., 
2017). We recently showed that TNX is expressed not only in connective tissue, but also in colonic 
intrinsic neurones, and that it is required for normal neural control of colonic motility (Aktar et al., 
2018). Our data suggested a direct role in cholinergic control, but we also found that absence of TNX 
leads to hypertrophy and hypersensitivity of nociceptive sensory nerve endings in the colon which do 
not themselves express TNX, therefore suggesting an indirect role in pain. These observations in 
knockout mice correlated closely with GI symptoms in genetically confirmed TNX-deficient patients 
with hEDS, including disrupted motility and bowel habit, and visceral pain (Aktar et al., 2018). There 
remains, however, a large gap in our understanding, since patients with hEDS suffer from symptoms 
that are localised in both upper and lower GI tract. The most common upper GI symptoms include 
bloating, reflux, disordered gastric emptying of a meal, nausea and indigestion (Castori et al., 2010; 
Mathias et al., 2012; Fikree et al., 2014). We set out to investigate firstly if there was a systematic link 
between TNX gene deficiency and symptoms in humans, and secondly what is the underlying 
mechanism. In particular, vagal afferent fibres innervating the upper gastrointestinal tract play a 
critical role both in initiation of symptoms and reflexes controlling several functions (Page & 
Blackshaw, 2009), Vagal afferents are comprised of two main types: firstly mucosal endings that 
respond to touch and to chemical stimuli; secondly muscular endings that respond optimally to 
mechanical stretch or tension (Page et al., 2002) These gastric mechanoreceptors have been 
anatomically identified as intraganglionic laminar endings (IGLE). Another population of intramuscular 
arrays (IMA) may also play a role in mechanosensation (Zagorodnyuk et al., 2001). They project to 
the brain stem whereupon they provide input to central sensory pathways and motor programmes 
(Browning & Travagli, 2010).  
 
We first investigated the correlation between TNX gene deficiency and symptom severity in a hEDS 
patient cohort. We then determined TNX expression in calretinin-immunoreactive structures 
analogous with vagal afferent endings in both humans and mice. Electrophysiological recordings were 
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used to show if TNX knockout mice have altered sensitivity of vagal afferents to gastric distension. 
The association of changes in vagal afferent function with overall gastrointestinal function was 
explored by measuring gastric emptying in vivo. We also investigated a means of normalising afferent 
function by activation of inhibitory GABAB receptors on gastric vagal afferents. What emerges is an 
inhibitory role for TNX in a specific population of upper GI mechanosensory neurones, which may 
underlie fundamental aspects of sensory signal transduction at afferent endings. Our findings further 
indicate these endings may be therapeutic targets for a range of symptoms in patients with TNX 
deficiency and may have a role in other patients such as those with hEDS. 
 
MATERIALS AND METHODS 
 
Ethical Approval 
Full-thickness gastric tissue (non-pathological) was obtained from cancer patients (>10cm away from 
tumors) undergoing gastrectomy using approved Human Research Ethics from Bart’s and London 
NHS Trust with informed consent (NREC 09/H0704/2). Unfortunately we could not obtain tissue from 
TNX deficient patients, however, TNX deficient patients gave written informed consent prior to 
completing questionnaires.  
All studies were completed according to the animal ethics policy and the study is in compliance with 
guidelines (Grundy, 2015). All mice used in these studies were killed by asphyxiation using carbon 
dioxide in accordance with the UK Home Office (Schedule 1, Animals Act 1986) for all experimental 
procedures. All human questionnaire studies were not registered in a database in accordance with the 
Helsinki Declaration.  
 
Mouse Tissue 
Mice used in this study originated from parent mice with a C57BL/6N background and donated by 
Professor Manuel Koch (University of Cologne). The generation of these mice have been previously 
described (Mao et al., 2002), (Aktar et al., 2018). Knockout and wild-type mice were phenotypically 
healthy, grew similarly and were of similar weight at the time of the study (WT: 19.9±0.8g and KO: 
20.8±1.1g). All mice were reared and transported under conditions specified in the UK’s Animal 
Welfare Act 2006. Mice aged between 10-12 weeks were used and were killed by a rising 
concentration of CO2 asphyxiation (Schedule 1, Animals Act 1986, U.K. Home Office).  
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Immunohistochemistry 
Immunolabelling with rabbit polyclonal TNX (1:200, Santa Cruz, sc-25717), calretinin (1:500, Swant, 
CG1 and 6B3) and calcitonin gene-related peptide CGRP (1:400-Abcam-ab36001 and Thermo 
Fisher- ABS026-05-02) was assessed in human and mouse specific stomach regions. Additionally, 
choline acetyl transferase ChAT (1:400-Abcam-ab18736) was used in brainstem sections.  
 
Immunohistochemistry process 
Tissue was fixed in 4% paraformaldehyde, 10µm sections and wholemounts were prepared, then 
blocked in universal blocking serum (Dako) and incubated overnight at 4
o
C with primary antibodies. 
Slides/whole mount tissue was then incubated for 1hr at room temperature with AlexaFluor 
conjugated secondary antibody as appropriate. Slides/whole mounts were then mounted using a 
coverslip and Vectashield Hardset Mountant conjugated with DAPI (H-1500) and left to dry before 
viewing under the microscope at 40x.   
 
Vagal Afferent Recording Studies 
Methodology used here was modified from Page (Page et al., 2002), as whole stomach was used. 
Once a distension-sensitive fibre was identified, 1ml of Krebs solution was infused via a cannula into 
the mouse stomach for 1min. After 1min the cannula was removed and the stomach was allowed to 
drain naturally. The empty stomach was then allowed to rest for 5min before repeating this process 
twice more. Separate TNX-KO mice were used for baclofen studies, whereby post two distension 
recordings baclofen (100µM) was infused into the organ bath as well as injection directly into the bath. 
After 10mins of baclofen infusion, two further distensions were made with a 5min rest in between to 
measure the effects of baclofen on afferent firing. Gastric compliance was measured using a pressure 
transducer which was attached to the cannula used to infuse the stomach with with standard volumes 
of Krebs solution. Single units were discriminated using wavemark analysis via Spike2 software 
(Cambridge Electronic Design Ltd.).  
 
Gastric Emptying Studies 
Mice were fasted overnight, placed in separate chambers, then consumed an egg yolk meal 
containing 1µl/1g C
13
 octanoic acid (99% enrichment, Cambridge Isotope Laboratories, Andover, MA, 
USA). Once fully consumed, breath samples were collected at intervals up to 150min and analysed 
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for 
13
CO2/
12
CO2 using the isotope-ratio mass spectrometer (Thermo Finnigan, Germany). Excretion 
data was analysed using non-linear regression analysis for curve fitting to obtain gastric emptying 
half-life (T½) and time taken for solid digestion into the duodenum (T-lag) (Ghoos et al., 1993).  
Primary cell culture and calcium imaging of nodose ganglia  
Primary cell cultures from the nodose ganglia of 12 week old WT and TNX-KO mice were prepared. 
Both nodose ganglia were removed under a stereomicroscope and placed immediately in cold F12 
complete nutrient medium. The ganglia were dissociated by enzymatic digestion in two steps. First by 
collagenase II and dispase 3mg/ml in HBSS with agitation at 5min intervals over 30mins and then by 
collagenase II alone for 15mins. After incubation the ganglia were rinsed in cold HBSS and F12 and 
further dissociated by trituration using a fine pipette. Cells were then pelleted, rinsed in HBSS and 
resuspended in Neurobasal A medium. The cells were plated on poly-D-lysine coated 24 well plates 
and placed in a 5% CO2 incubator at 37 °C for 2h to allow cell adherence. After 2h, warmed complete 
NBA medium (supplemented with B-27, penicillin/streptomycin and glutamax) was added to each well 
and incubated for 48hrs before experiments.  After 2 days of incubation cell cultures were loaded with 
Fluo-4-AM as described in protocol detects calcium flux and was loaded 1hr before rinsing the cells 
with Krebs and reloading with Krebs. Changes in intracellular Ca
2+
 concentration [Ca
2+
] are reflected 
in Fluo-4-AM fluorescence intensity and recorded at 525/50 nm. Baseline activity of identified 
neurones was recorded for 120s and then stimulated with either capsaicin (100 nM), CCK (10nM) or 
KCl (50mM) for 120s. Images were acquired every 5s with a confocal Zeiss LSM 880 with Airyscan 
using Zen software. Changes in flourescence intensity were measured by drawing a region of interest 
around neurones, then measuring change in fluorescence intensity. The total number of neurones 
that responded to stimuli were then averaged over a single time point.  Peak intensity within the first 
10s was measured in cell cultures from both mouse groups. Identified neurones that changed in 
intensity due to the stimuli was described as a responder, while a non-responder was described as 
neurones that showed no changes in fluorescence intensity. The total number of neurones that 
responded to capsaicin, cholecystokinin (CCK) and KCl was individually noted. We sampled nodose 
ganglia neurones randomly to see if TNX deficient neurones respond differently as a population; 
more subtle changes may be revealed using patch clamp recordings from neurone retrogradely 
labelled from the stomach. 
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Patient genotyping   
11 patients (3 males and 8 females) identified from Radboud University Medical Centre took part and 
were genotyped for TNXB (Schalkwijk et al., 2001). Mutation analysis was performed using next-
generation sequencing (NGS) testing TNXB DNA mutation, as previously described (Demirdas et al., 
2016). Additionally, serum samples were analysed for TNX glycoprotein using ELISA with rabbit anti-
TNX.  
 
GI symptom questionnaire 
Patients with TNX deficiency completed a Flemish version of the validated Gastrointestinal Symptom 
Rating Scale (GSRS) (Svedlund et al., 1988). Questionnaire responses were translated and scored 
for 5 different domains – reflux, abdominal pain, constipation, indigestion, and diarrhoea. Scores 
ranged from 1 (no symptoms) to 7 (unbearable symptoms). GSRS scores for abdominal pain and 
upper GI symptoms for reflux and indigestion were analysed in TNX deficient patients compared to a 
reference Swedish population of similar age and sex (Dimenas et al., 1996).  
 
Experimental design and Statistical analysis 
Immunohistochemistry: Qualitative images were obtained for both human and mouse stomach. 
Controls with no primary antibody were performed with each run of immunohistochemistry to confirm 
the specificity of the primary antibody, which resulted in no fluorescence above background.  
Western blot with this antibody in humans revealed a band at the predicted weight of 268kD. 
Moreover TNX was absent in all TNX-KO gut tissue. Images were obtained using Metamorph 
software on Olympus MM Leica (sections) or Zen software on Zeiss LSM 710 or Zeiss LSM 880 
(confocal imaging-wholemounts) at 40x magnification.   
Vagal afferent recordings: A total of 12 WT and 12 KO mice (6 females and 6 males in both groups) 
were used to measure spontaneous and post distension afferent activity in the stomach. Separate 
baclofen experiments in N=4 WT vs. N=4 KO mice (2 females and 2 males in both groups) were also 
performed. Data were statistically analysed with an unpaired t test and individual data were plotted for 
all data sets with a p-value of <0.05 was deemed significant. 
Gastric emptying: A total of N=9 WT vs. N=15 KO mice (5 females and 4 males in WT and 7 females 
and 8 males in KO) were used. Statistical analysis was performed with an unpaired t test to compare 
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between mouse groups and individual data were plotted with a p-value of <0.05 was deemed 
significant. 
Calcium Imaging: A total of N=5 WT vs. N=5 KO mice (3 females and 2 males in both groups) were 
used. In total 25 WT and 17 KO individual nodose neurones were stimulated with KCL and capsaicin 
respectively while 18 WT and 34 KO individual nodose neurones were stimulated with CCK. Statistical 
analysis was performed using an unpaired t-test. Individual data were plotted and a p-value of <0.05 
was deemed significant. 
Patient questionnaires: 11 patients (3 males and 8 females) with TNX deficiency were used and 
compared to a reference Swedish population N=2162. The reason for the small sample size in TNX 
deficient group was due to a small number of patients known to have TNX deficiency since it is 
uncommonly measured. Questionnaire data are shown as mean values with standard deviation. 
Statistical analysis was performed using an unpaired students t-test for each symptom, p<0.05.  
 
All data are expressed as individual data points and variability within the data was represented using 
95% confidence intervals of the mean. Statistical analysis was performed using GraphPad Prism 
(V.7.02, GraphPad Software, Inc). 
 
RESULTS 
 
TNX localisation in Mouse and Human stomach 
Calretinin-IR is a well-established marker for vagal afferents in rodent upper gut, and reliably labels 
intraganglionic laminar endings (IGLE) and intramuscular arrays (IMA) (Berthoud et al., 1995; Fox et 
al., 2000; Phillips & Powley, 2000; Powley et al., 2013). In the mouse stomach, fibres positive for 
TNX+calretinin were seen in circular muscle (Fig 1B). Fibres in stomach showed partially overlapping 
IR for calretinin and TNX and corresponded anatomically and neurochemically to IMA (Fig 1B) and 
IGLE (Berthoud & Neuhuber, 2000). TNX and calretinin-IR colocalisation was also observed 
surrounding myenteric ganglia in IGLEs (Fig 1A), which have been previously described as tension-
sensitive vagal afferents (Berthoud & Powley, 1992; Phillips & Powley, 2000; Zagorodnyuk et al., 
2001). Correspondingly, TNX-IR was found in a subpopulation of cell bodies of vagal afferent 
neurones in the nodose ganglia (Fig 1C) and more centrally in punctate endings within the nucleus 
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tractus solitarius, some in close proximity to dendrites of TNX-negative ChAT-positive neurones 
(presumably vagal preganglionic motorneurones) in the adjacent dorsal motor nucleus of the vagus 
(Fig 1D). Peripherally, qualitative analysis shows some TNX-IR cell bodies were present in gastric 
myenteric ganglia of human fundus (Fig 1E) but not in mouse (Fig 1A). CGRP did not co-label with 
TNX in human fundus (Fig 1F). Similar to the mouse circular muscle, TNX-IR IMA were also found in 
human smooth muscle (Fig 1G).  
 
Gastric Vagal Afferent Sensitivity in Mice 
 
The pattern of TNX localisation in calretinin-IR endings in the stomach suggested a role in vagal 
afferent (IGLE and IMA) function, therefore we investigated if there was an alteration in 
mechanosensory and electrophysiological properties of gastric vagal afferents that lack TNX. Single 
afferent fibre recordings of gastric tension receptors that are mechanosensitive to contraction and 
distension exhibiting slow adaptation to innocuous wall tension (Page et al., 2002) were analysed. 
Spontaneous firing was significantly increased by 66% in TNX-KO compared to WT (0.23± 0.06 WT 
vs 0.69± 0.08 KO, p=0.0003) (Fig 2C). Similarly, responses to distension were significantly increased 
in TNX-KO (2.37± 0.67 WT vs 9.67± 1.2 KO, p<0.0001) (Fig 2D). Distension-induced changes in 
intragastric pressure showed no difference in area under curve (1598.9± 168.2 WT vs 2055.6± 177.9 
KO, p=0.7326) (Fig 2E). Therefore, gastric compliance is unaltered suggesting increased afferent 
sensitivity in TNX-KO is a property of the afferent neurones, not their environment.  
Rescue of afferent hypersensitivity in TNX-KO mice 
Addition of the GABAB receptor agonist- baclofen caused a significant reduction in spontaneous firing 
(0.69± 0.08 KO vs 0.13± 0.029 KO+baclofen, p<0.0001), Fig 2C) and afferent firing during distension 
in TNX-KO (9.67± 1.2 KO vs 1.55± 0.253 KO+baclofen, p<0.0001), Fig 2D). Afferent firing post 
baclofen was reduced in TNX-KO mice similar to levels observed in WT mice (Fig 2C). 
 
Gastric Emptying  
Since vagal afferents showed mechanical hypersensitivity in the absence of TNX, we asked if this 
translated to reflex control of gastric motility by observing gastric emptying in TNX-KO. In WT, a 
gradual increase in labelled CO2 ultimately peaked at 90 mins, while TNX-KO mice had a rapid 
increase which peaked at 60 mins (Fig 3A). Starting at 100 mins, CO2 gradually declined in WT mice 
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unlike TNX-KO that had a rapid decline at 75mins, demonstrating faster gastric emptying (Fig 3A). 
The T½ (158min± 21.8 WT vs 103min±12.9 KO, p=0.0277) (Fig 3B) and T-Lag (24min± 2.7 WT vs 
38min± 5.7 KO, p=0.0194) (Fig 3C) were significantly reduced in TNX-KO suggesting that propulsive 
motility of the stomach is enhanced.  
 
Excitability of cultured nodose ganglia 
Vagal afferent hypersensitivity could be due to altered generation of action potentials by mechanical 
stimuli at the endings or by altered excitability of the neurone as a whole. To determine which is most 
likely, nodose ganglia neurones were isolated from their target and studied in culture. They grew 
similarly (Fig 4A) in both WT and KO mice indicating a lack of influence of TNX on cytoarchitecture 
and viability. Responsiveness was assessed by peak calcium responses within the first 10s post-KCl, 
CCK and capsaicin, which showed no differences between WT or TNX-KO neurones (Fig 4B). 
Additionally there were no differences in the number of responders versus non-responders to KCl, 
CCK and capsaicin between groups (Fig 4C). Thus the changes we observed are most likely due to 
mechanical hypersensitivity. 
 
 
Gastrointestinal Symptoms in TNX deficient patients 
TNX deficient patients showed significantly increased severity of GI symptoms overall (p<0.0001) 
compared to healthy controls (Fig 5). Specifically, symptoms of gastroesophageal reflux, abdominal 
pain and indigestion were all significantly increased.  
 
DISCUSSION 
Having recently discovered a novel role for TNX in enteric neurones of the lower GI tract, it followed 
that there was a likely role also in the upper gut, particularly in view of the fact that patients with TNX 
deficiency have upper as well as lower GI symptoms. We found a strong correlation between TNX 
gene deficiency and upper GI symptom severity in a patient cohort. Correspondingly, TNX was 
normally present in calretinin-immunoreactive structures, analogous with vagal afferent endings in 
both humans and mice. Electrophysiological recordings showed that TNX knockout mice have greatly 
enhanced sensitivity of vagal afferents to gastric distension. This is associated with accelerated 
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gastric emptying in vivo, and matches the upper GI symptoms reported by patients. We also show 
that  increased afferent function can be reversed by activation of inhibitory GABAB receptors on 
gastric vagal afferents. Thus TNX plays an inhibitory role in a specific population of upper GI 
mechanosensory neurones, and may underlie aspects of sensory signal transduction at afferent 
endings. Our findings further indicate these endings may be therapeutic targets for a range of 
symptoms in patients with TNX deficiency and may have a role in other patients such as those with 
hEDS. 
 
TNX-IR was found in a small population of nodose ganglion neurones and in sparse central vagal 
terminals in the NTS. Therefore we corroborated our finding in hindgut that TNX is expressed by GI 
neurones, but with the exception that expression in upper gut is in extrinsic, rather than intrinsic 
neurones. This indicates a very different role for TNX in the upper GI tract. TNX-IR was seen often in 
endings that colocalised with calretinin. It is established from other work that these are vagal afferent 
terminals with cell bodies in the nodose ganglia (Berthoud et al., 1995; Fox et al., 2000; Phillips & 
Powley, 2000; Powley et al., 2013), which fits with the lack of TNX-IR intrinsic cell bodies. 
Correspondingly, Based on this finding of TNX expression in extrinsic neurones, it was important to 
determine if TNX influences vagal afferent function, which we investigated with a gastric vagal afferent 
preparation adapted from those we have used before (Page et al., 2002) to reveal differences 
between genotypes. We observed greater mechanosensitivity and baseline discharge of individual 
low-threshold distension-sensitive afferents, known as tension receptors (Page et al., 2002).  This was 
in the absence of changes in gastric compliance, suggesting it was a property of the nerve endings 
only. This notion was further supported by studies of nodose ganglion cell bodies, which showed no 
difference in responsiveness after application of KCl, CCK or capsaicin. This leads us to believe that 
TNX plays a specialised role in the anchoring of nerve terminals to their targets, perhaps by allowing 
flexibility between the two. Thus, without TNX the afferent ending becomes less dynamic in its 
attachment and reaches full mechanical distortion with less movement relative to the surrounding 
tissue. We speculate on this in Fig 6, in which the spacing of mechanosensory terminals and smooth 
muscle elements is critical for normal afferent signalling. It will require further studies with electron 
microscopy to see if this anchoring role is tenable. In our previous study of high threshold nociceptive 
colonic afferents in the splanchnic nerves (Aktar et al., 2018), we also found increased 
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mechanosensitivity in the TNX-KO, but TNX labelling was not associated with the endings themselves 
and was in fact mutually exclusive with their marker – CGRP. In that case there was approximately a 
50% greater mechanosensitivity in the knockout, whereas here we found a 400% greater 
mechanosensitivity, which is perhaps not surprising given the direct association of TNX with vagal 
afferents compared with the distinct location of TNX relative to splanchnic afferents. This is by far the 
biggest difference in vagal function we have seen in several comparisons of knockouts of sensory 
genes with wild types, suggesting the role of TNX is critical. The indirect role of TNX in splanchnic 
afferents is supported by the fact that they appeared to sprout into the otherwise TNX-negative 
mucosa (Aktar et al., 2018)  (suggesting a barrier function), whereas their direct role in vagal afferents 
is supported by the observation that their anatomical relation to other tissues was not noticeably 
altered in TNX-KO, but their function was markedly different. 
 
The main expected consequence in vivo of increased gastric vagal afferent sensitivity, upon reaching 
the central nervous system (CNS) would be increased perception of non-nociceptive mechanical 
forces in the stomach, but mouse models are not available for this. Therefore we investigated another 
major consequence of vagal afferent activation, which is the control of gastric emptying (Browning et 
al., 2014). This is mediated via a vago-vagal reflex in the brain stem, where indeed we saw 
localisation of TNX presumably at the central endings of vagal afferents. It is known that distension of 
the proximal stomach promotes motor activity of the distal stomach via this reflex, which serves to 
augment the antral pump, which in turn facilitates emptying of solids from the stomach through the 
pylorus into the duodenum (Grundy et al., 1989), (Andrews et al., 1980). There was a faster rate of 
gastric emptying of a solid meal in TNX-KO that was comparable to the greater afferent sensitivity, 
which supports a role for TNX in this pathway in vivo. Although studies of gastric emptying specifically 
in TNX-deficient patients are lacking, some studies of emptying in ungenotyped hEDS patients show 
increased solid emptying (Menys et al., 2017), suggesting the same phenomenon. Through 
comparison of GSRS questionnaire data, we were able to determine if TNX-deficient patients reported 
upper GI symptoms differently to controls, and we found that in the cases of perception of indigestion 
and reflux, scores were approximately double in the TNX-deficient cohort compared to controls. This 
is in addition to lower GI symptoms we already reported in this cohort.  
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The data presented here would suggest that all upper GI symptoms in TNX-deficient patients (and 
possibly therefore those reported in a large number of hEDS patients) may have a common origin in 
the hypersensitivity of vagal afferents. In that case it would make these endings a potential 
therapeutic target. This has been suggested before, when the triggering of transient lower 
oesophageal sphincter relaxations by vagal afferents through a similar pathway was exploited as a 
therapeutic target for gastro-oesophageal reflux disease (Tonini et al., 2004). Specifically, the 
expression of GABAB receptors by vagal afferents was exploited as a means of reducing their 
excitability, and thus the strength of their signal to the central motor programme giving rise to 
sphincter opening that allows acid reflux (Zhang et al., 2002). This was done, and almost succeeded 
in clinical trials, despite the lack of any evidence for hypersensitivity of vagal afferents in gastro 
oesophageal reflux disease (GORD). Here though, we have a demonstrable hypersensitivity that is 
specific to mechanical stimuli, that we know is susceptible to inhibition via GABAB receptors. 
Therefore we sought to rescue the hypersensitivity of vagal afferents using the prototypic GABAB 
receptor agonist baclofen. This was highly effective, with profound inhibition of responses to 
distension as well as spontaneous activity. Unfortunately baclofen has considerable effects on the 
CNS (Dario et al., 2007), so it was not possible to determine if these effects seen in the organ bath 
were translatable to in vivo experiments on gastric emptying. For that a more peripherally restricted 
compound would be required.  
 
Generally speaking, mouse and human data were comparable in this study in terms of differences 
between TNX-deficient and control cohorts. However, not all parameters could be assessed, such as 
gastric emptying in TNX-deficient patients (for ethical reasons related to their primary referral), and 
upper GI symptoms in mice (because of lack of outcome markers). In the case of TNX localisation, we 
were able to compare directly the two species, and we did find discrepancy. Whereas the mouse 
lacked completely any somatic labelling in gastric myenteric neurones for TNX, human specimens 
invariably showed gastric myenteric neurones were TNX-IR, albeit at a much lower abundance than 
those in the lower GI tract. This may suggest the neuronal subtypes may differ between species, and 
indeed it has been noted before that very few or no AH/Type II myenteric neurones are found in the 
upper GI tract of some species, but not others (Mazzuoli & Schemann, 2012). Of importance is the 
observation that larger mammals are more likely to possess these neurones, which means that TNX-
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IR may be serving as a marker for this population, along with calretinin (although not exclusively). This 
would fit with the far higher prevalence of TNX+calretinin-IR enteric neurones in the colon, where 
AH/Type II neurones are common in all species. It was not possible to observe fine anatomical detail 
of neurones labelled in this study, and therefore their Dogiel type, but the colocalisation of TNX with 
calretinin is a further indicator that this is their phenotype. Intrinsic AH/Type II neurones more closely 
resemble extrinsic sensory neurones than other functional subtypes in the ENS, so it may be that TNX 
associates exclusively with a non-nociceptive sensory phenotype, since of course vagal afferents are 
also sensory neurones.  
 
Perineuronal nets (PNN) are a feature of central synapses, and are formed by the interaction of 
another tenascin, tenascin-R, with various ECM components (Sorg et al., 2016). PNN are involved in 
structural connections between neurones and in synaptic plasticity (Kwok et al., 2011). We have no 
indications from our data as to whether or not TNX fulfils such a role in the gut or in the dorsal vagal 
complex, since labelling of other ECM components is required to do this definitively. However, it is 
intriguing how IGLE form a basket-like network around myenteric ganglia, which may serve a 
structural role in the delineation of discrete ganglia in the ENS. The location and orientation of IGLE 
and IMA would simultaneously assist in their mechanosensory function by detecting force impinging 
between and within smooth muscle layers.  
 
Could differences in afferent endings lacking TNX reflect a role for TNX in correct spacing of afferent 
terminals relative to host tissue? By comparison, the ECM molecule agrin is thought to be important in 
forming neuromuscular junctions and maintaining synapses between cholinergic preganglionic axons 
and sympathetic neurons (Gingras et al., 2002). Mice lacking a part of the agrin molecule show 
marked reduction in acetylcholine receptor which indicates this molecule is crucial in normal synapse 
function in the CNS (Gingras et al., 2002), (Gautam et al., 1996 4716). Moreover, agrin increases 
nicotinic transmission at the synapse by modulating the space between the gap-junction-mediated 
electrical coupling (Martin et al., 2005). Similar to agrins, TNX may have a role in modulating the vagal 
afferent microenvironment by regulating the intercellular spaces between the vagal afferent terminals 
and smooth muscle or interstitial cells of Cajal. Therefore, it is likely that TNX plays a similar role to 
other ECM proteins in modulating neural connectivity. Perhaps TNX is important in maintaining the 
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shape of vagal afferent endings, therefore the absence of TNX may transduce mechanical forces less 
dynamically. The morphology of vagal afferent endings in the KO model was not altered therefore this 
needs to be further explored at the ultrastructural level. 
 
In TNX deficiency, in addition to extracellular abnormalities, ion channels that detect mechanical 
sensitivity may be altered, thus affecting the movement of sodium influx initiating the action potential. 
This change could then result in increased afferent firing observed in the KO. Interestingly, TNR is 
shown to modulate the activity of sodium channels that are involved in action potential generation 
(Weber et al., 1999), in particular cells containing β1 and β2 subunits (Xiao et al., 1999). TNR 
deficient mice show no change in the distribution of sodium channels, but action potentials recorded 
from optic nerves showed a significant decrease in conduction velocity (Weber et al., 1999). Since 
TNX and TNR are within the same family, the functional importance of voltage gated sodium channels 
may similarly be affected by their removal. 
In conclusion, we propose that TNX serves at least two important roles in gastrointestinal neural 
function, in addition to its established role in the structure and rigidity of somatic tissues. These are: a 
positive influence on cholinergic neurotransmission in intrinsic enteric neurones in the intestine, and a 
negative influence on mechanical coupling of vagal afferent endings in the stomach.  These 
seemingly opposite effects may both ensue from changes in ultrastructure. 
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FIGURE LEGENDS 
Figure 1: TNX is expressed in neural structures in the stomach. Representative 
Immunohistochemical images taken from whole mount mouse fundus labelled with TNX and calretinin 
in IGLE surrounding the MP but not in cell bodies (A). TNX-IR was commonly found in calretinin-IR 
fibres in the smooth muscle layer of the stomach (B-Merge). The cell bodies of vagal afferents in the 
nodose ganglia also showed positive TNX and calretinin co-labelling in sections (C-Merge). TNX 
positive endings found in the mouse NTS (nuclus tractus solitarius). Unlike mouse, human fundus 
sections showed TNX- and calretinin-IR cell bodies in the MP (E-Merge) that were distinct from CGRP 
fibres (F-Merge). TNX also co-labelled calretinin-positive endings in the circular smooth muscle (G-
Merge). All images from mouse and human stomach are whole mount confocal z images except for 
nodose ganglia and circular muscle image taken with an epi-fluorescent microscope. DMN denotes 
dorsal motor nucleus. Scale bar in panels A, B and C=25μm, C, D, E= 30μm  
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Figure 2: Vagal afferent mechanosensitivity in WT and TNX-KO mice. Responses to distension 
from single vagal afferent units innervating the stomach in WT vs. KO. Nerve discharge rate 
(histogram) was increased in KO in both spontaneous and distended (1mL of fluid in stomach) 
conditions (A). B shows the corresponding raw trace to the nerve discharge rate. Spontaneous (C, 
p=0.0003) and distension (p<0.0001) induced afferent firing (D) was significantly increased in TNX-
KO compared to WT, (n=14 WT afferent units vs. n=18 KO afferent units). Addition of Baclofen 
(100µM) significantly reduced both spontaneous (p<0.0001) and distension (p<0.0001) induced firing 
back to similar levels observed in WT mice (C, D, n=23 KO afferent units). Baclofen also reduced WT 
spontaneous (p<0.0001) and distension (p=0.028) induced firing (C, D, n=22 WT afferent units). 
There was no change in gastric compliance to 1ml Krebs over 1 min in WT vs TNX-KO mice (N=12 
WT vs. N=12 KO). (E). Statistical analysis was performed using an unpaired t-test. 
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Figure 3: Gastric emptying in WT and TNX-KO mice. Mean results showing 
13
CO
2
 excretion curve 
in WT vs. KO. KO curve (grey) shows an increase in gastric emptying rate since the curve has shifted 
to the left (A). The half-life (T½) was significantly reduced in the KO (103±12.9 min) p=0.0277 (B). The 
time taken for solid food to be broken down (T-Lag) was significantly reduced in the KO: 24min ±2.7 
p=0.0194. (N=9 WT vs. N=15 KO). Statistical analysis was performed using an unpaired t-test. 
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Figure 4: Capsaicin and CCK effects in cultured nodose neurones  
 
Differential interference contrast (DIC) image of neurones in culture, at baseline and stimulated 
neurone (A). The average peak intensity within the first 10s shows no change in response to KCl, 
capsaicin or CCK (B). Numbers of responsive and non-responsive neurones show no change in WT 
and KO with KCl, capsaicin or CCK stimulation (C).n=25 WT vs. n=17 KO KCL/capsaicin experiments 
and n=18 WT vs. n=34 KO CCK experiments, 
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Figure 5: Gastrointestinal symptoms in TNX deficient patients and healthy controls. The 
severity of gastrointestinal symptoms assessed using the gastrointestinal symptom rating scale 
(GSRS) scores (means and 95% CI) in patients with TNX deficiency (N=11) and healthy controls 
(N=2162). Abdominal pain, reflux and indigestion was significantly higher in TNX deficient patients 
compared to Swedish controls (****, p< 0.0001). Statistical analysis was performed using a two-way 
ANOVA (Sidak multiple comparison test). 
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Figure 6: Hypothesized anti-adhesive mechanisms by which TNX supports sensory function. In 
the stomach, vagal afferent endings are maintained at an optimal attitude to the host tissue by TNX, 
whether that be ganglia or muscle, or possibly interstitial cells (not shown). Without TNX, the ECM is 
improperly supported so excessive strain, both resting, and particularly active, is exerted on the 
mechanosensitive elements of the afferent ending. 
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